Belite Bio, Inc. logo

Belite Bio, Inc.

10 Marks
Other
First Filed:Oct 31, 2018Latest Filed:May 4, 2026Address:PO Box 309, Ugland House, Grand Cayman, KY1-1104, 00000, KY

Portfolio Overview

Top Classes

Class 42
Software, IT Services & Scientific Research
6(60%)
Class 5
Pharmaceuticals
6(60%)

TTAB Proceedings

No litigation activity

Top Firms

Loading...

Trademark Portfolio

10 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
BELITE BIO
BELITE BIO
Trademark
Combined
PENDING
Owner:
Serial:99803688
Filed:May 4, 2026
Classes:5, 42
Description: Class 5: Pharmaceutical preparations for the treatment and prevention of ophthalmic disorders; Pharmaceutical preparations for the treatment and prevention of metabolic syndromes; Pharmaceutical preparations for the treatment and prevention of cancer
Class 42: Pharmaceutical research and development services; Development of pharmaceutical preparations and medicines; research and development of pharmaceuticals for the treatment of ophthalmic disorders, metabolic syndromes, and cancer
PHOZOVO
PHOZOVO
Trademark
Word
PENDING
Owner:
Serial:99652384
Filed:Feb 13, 2026
Classes:5
Description: Pharmaceutical and biopharmaceutical drugs and medicines for treatment of degenerative retinal diseases
PHOZOVO
PHOZOVO
Service Mark
Word
PENDING
Owner:
Serial:99652387
Filed:Feb 13, 2026
Classes:42
Description: Research and development of pharmaceutical and biopharmaceutical drugs and medicines for the treatment of degenerative retinal diseases; Research and development in the pharmaceutical, life sciences and biotechnology fields
VUEKENSE
VUEKENSE
Service Mark
Word
PENDING
Owner:
Serial:99652376
Filed:Feb 13, 2026
Classes:42
Description: Research and development of pharmaceutical and biopharmaceutical drugs and medicines for the treatment of degenerative retinal diseases; Research and development in the pharmaceutical, life sciences and biotechnology fields
VUEKENSE
VUEKENSE
Trademark
Word
PENDING
Owner:
Serial:99652370
Filed:Feb 13, 2026
Classes:5
Description: Pharmaceutical and biopharmaceutical drugs and medicines for treatment of degenerative retinal diseases
VUEZURA
VUEZURA
Trademark
Word
PENDING
Owner:
Serial:99652396
Filed:Feb 13, 2026
Classes:5
Description: Pharmaceutical and biopharmaceutical drugs and medicines for treatment of degenerative retinal diseases
VUEZURA
VUEZURA
Service Mark
Word
PENDING
Owner:
Serial:99652403
Filed:Feb 13, 2026
Classes:42
Description: Research and development of pharmaceutical and biopharmaceutical drugs and medicines for the treatment of degenerative retinal diseases; Research and development in the pharmaceutical, life sciences and biotechnology fields
YOOKANSI
YOOKANSI
Trademark
Word
PENDING
Owner:
Serial:99652360
Filed:Feb 13, 2026
Classes:5
Description: Pharmaceutical and biopharmaceutical drugs and medicines for treatment of degenerative retinal diseases
YOOKANSI
YOOKANSI
Service Mark
Word
PENDING
Owner:
Serial:99652365
Filed:Feb 13, 2026
Classes:42
Description: Research and development of pharmaceutical and biopharmaceutical drugs and medicines for the treatment of degenerative retinal diseases; Research and development in the pharmaceutical, life sciences and biotechnology fields
BELITE BIO
BELITE BIO
Trademark
Word
REGISTERED
Owner:
Serial:88176499
Filed:Oct 31, 2018
Classes:5, 42
Registration:6003555
Registered:Mar 3, 2020
Description: Pharmaceutical preparations for the treatment of and prevention of ophthalmic disorders; pharmaceutical preparation for the treatment of and prevention of metabolic syndromes; pharmaceutical preparations for the treatment of cancer; "BIO"; Pharmaceutical research and development services; development of pharmaceutical preparations and medicines; research and development of pharmaceuticals for the treatment of ophthalmic disorders, metabolic syndromes, and cancer